Q-Pharm Pty Ltd
Herston, Queensland, Australia
Association or organization
300C Herston Rd, Fortitude Valley QLD 4006
About Q-Pharm Pty Ltd
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Acrux DDS Pty Ltd
2
Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.
1
Allergan
1
Angitia Biopharmaceuticals
1
Attralus, Inc.
1
BeiGene
1
Celltrion
1
Codagenix, Inc
1
De Motu Cordis
1
HighTide Biopharma Pty Ltd
1
Immune Targeting Systems Ltd
1
Clinical Trials at Q-Pharm Pty Ltd
During the past decade, Q-Pharm Pty Ltd conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on
average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
To Determine the Effects of Deodorant, Antiperspirant and Washing on the Pharmacokinetics of 2% Testosterone MD Lotion
2009-01-01
2009-04-01
Completed
36
Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1)
2012-01-01
2012-09-01
Completed
48
Study to Evaluate the Immunogenicity and Safety of an Ebola Virus (EBOV) Glycoprotein (GP) Vaccine in Healthy Subjects
2015-02-01
2016-04-01
Completed
230
Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease
2015-08-01
2017-01-06
Completed
38
A Multiple Ascending Dose Study of HTD1801 in Adults With Hypercholesterolemia
2018-04-13
2018-12-31
Completed
50
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Q-Pharm Pty Ltd" #1 sponsor was "Acrux DDS Pty Ltd" with 2 trials, followed by "Advaccine (Suzhou) Biopharmaceuticals Co., Ltd." with 1 trials
sponsored, "Allergan" with 1 trials sponsored, "Angitia Biopharmaceuticals" with 1 trials sponsored and "Attralus, Inc."
with 1 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Q-Pharm Pty Ltd"
#1 collaborator was "Novotech (Australia) Pty Limited" with 3 trials as a collaborator, "Angitia Australia Pty Ltd" with 1 trials as a collaborator, "Hangzhou Sciwind Biosciences Co., Ltd." with 1 trials as a collaborator, "INCResearch Australia Pty Limited" with 1 trials as a collaborator and "MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Q-Pharm Pty Ltd
According to Clinical.Site data, the most researched conditions in "Q-Pharm Pty Ltd" are
"Celiac Disease" (2 trials), "Amyloidosis; Systemic" (1 trials), "Anaphylactic Reaction" (1 trials), "Asthma" (1 trials) and "Bacterial Vaginosis" (1 trials). Many other conditions were trialed in "Q-Pharm Pty Ltd" in a lesser frequency.
Clinical Trials Intervention Types at Q-Pharm Pty Ltd
Most popular intervention types in "Q-Pharm Pty Ltd" are "Drug" (13 trials), "Biological" (6 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Testosterone MD-Lotion" (2 trials), "2x Base Dose EBOV GP Vaccine" (1 trials), "30 micrograms Nexvax2" (1 trials) and "4x Base Dose EBOV GP Vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Q-Pharm Pty Ltd
The vast majority of trials in "Q-Pharm Pty Ltd" are
15 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Q-Pharm Pty Ltd
Currently, there are NaN active trials in "Q-Pharm Pty Ltd".
2 are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Q-Pharm Pty Ltd,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Q-Pharm Pty Ltd, 18 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".